Articles by author - Barbora Stankova

N-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia.

Vecka M, Dušejovská M, Stankova B, Zeman M, Vavrova L, Kodydkova J, Slaby A, Zak A.

Controlled Clinical Trial 2012; 33(Suppl 2): 87-92 PubMed PMID: 23183517  Keywords:  Adult, Aged, Atherosclerosis:drug therapy, Drug Therapy, Combination, Dyslipidemias:drug therapy, Fatty Acids, Omega-3:administration & dosage, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors:administration & dosage, Hypertriglyceridemia:dr.    Citation

BACKGROUND: Atherogenic dyslipidemia contributes substantially to the residual cardiovascular risk. The aim of this study was to examine t.....

Read abstract  Full text PDF

Isolation and identification of the Amanita muscaria and Amanita pantherina toxins in human urine.

Merova B, Ondra P, Stankova M, Valka I.

Journal Article 2008; 29(5): 744-748 PubMed PMID: 18987593  Keywords:  Amanita:chemistry, Amanitins:urine, Chromatography, High Pressure Liquid, Humans, Ibotenic Acid:urine, Indicators and Reagents, Muscarine:urine, Muscimol:urine, Nucleic Acid Synthesis Inhibitors:urine, Solid Phase Extraction, Solvents, Spectrometry, Mass,.    Citation

OBJECTIVES: Ibotenic acid, muscimol and muscarine were recognized as responsible for psychotropic effects of A. muscaria and A. pantherina.....

Read abstract  Full text PDF